Quest for the rings. In silico exploration of ring universe to identify novel bioactive heteroaromatic scaffolds

Journal of Medicinal Chemistry

Volumn 49, Issue 15, 2006, Pages 4568-4573

  Ertl, Peter ^a   Jelfs, Stephen ^a   Mühlbacher, Jörg ^a   Schuffenhauer, Ansgar ^a   Selzer, Paul ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC COMPOUND; NATURAL PRODUCT; ORGANIC COMPOUND;

ARTICLE; ARTIFICIAL NEURAL NETWORK; BIOAVAILABILITY; COMBINATORIAL LIBRARY; DATA BASE; DRUG ACTIVITY; DRUG DESIGN; DRUG SCREENING; DRUG STRUCTURE; MOLECULAR LIBRARY; QUANTUM CHEMISTRY; STEREOCHEMISTRY; VIRTUAL REALITY;

BIOLOGICAL AVAILABILITY; DATABASES, FACTUAL; DRUG DESIGN; HETEROCYCLIC COMPOUNDS; HYDROCARBONS, AROMATIC; MOLECULAR STRUCTURE; NEURAL NETWORKS (COMPUTER); PHARMACEUTICAL PREPARATIONS; QUANTUM THEORY;

EID: 33746740077     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm060217p     Document Type: Article

References (28)

1. Downs, G. M.; Gillet, V. J.; Holliday, J. D.; Lynch, M. F. Review of ring perception algorithms for chemical graphs. J. Chem. Inf. Comput. Sci. 1989, 29, 172-187.
2. Roos-Kozel, B.; Jorgensen, W. Computer-assisted mechanistic evaluation of organic reactions. 2. Perception of rings, aromaticity, and tautomers. J. Chem. Inf. Comput. Sci. 1981, 21, 101-111.
3. Böhm, H.-J.; Flohr, A.; Stahl, M. Scaffold hopping. Drug Discovery Today: Techol. 2004, 1, 217-224.
4. Bemis, G. W.; Murcko, M. A. The properties of known drugs. 1. Molecular frameworks. J. Med. Chem. 1996, 39, 2887-2893.
5. Gibson, S.; McGuire, R.; Rees, D. C. Principal components describing biological activities and molecular diversity of heterocyclic aromatic ring fragments. J. Med. Chem. 1996, 39, 4065-4072.
6. Lipkus, A. H. Exploring chemical rings in a simple topological-descriptor space. J. Chem. Inf. Comput. Sci 2001, 41, 430-438.
7. Lewell, X. Q.; Jones, A. C.; Bruce, C. L.; Harper, G.; Jones, M. M.; McLay, I. M.; Bradshaw, J. Drug rings database with Web interface. A tool for identifying alternative chemical rings in lead discovery programs. J. Med. Chem. 2003, 46, 3257-3274.
8. Bohl, M.; Dunbar, J.; Gifford, E. M.; Heritage, T.; Wild, D. J.; Willett, P.; Wilton, D. J. Scaffold searching: automated identification of similar ring systems for the design of combinatorial libraries. Quant. Struct.-Act. Relat. 2003, 21, 590-597.
9. Broughton, H. B.; Watson, I. A. Selection of heterocycles for drug design. J. Mol. Graphics Modell. 2004, 23, 51-58.
10. Wilkens, S. J.; Janes, J.; Su, A. I. HierS: hierarchical scaffold clustering using topological chemical graphs. J. Med. Chem. 2005, 48, 182-193.
11. Koch, M. A.; Schuffenhauer, A.; Scheck, M.; Wetzel, S.; Casaulta, M.; Odermatt, A.; Ertl, P.; Waldmann, H. Charting biologically relevant chemical space: a structural classification of natural products (SCONP). Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 17272-17277.
12. ( 12) WDI, Derwent World Drug Index. http://www.derwent.com/products/lr/ wdi/.
13. MDDR. MDL Drug Data Report. http://www.prous.com/product/electron/mddr. html.
14. Dictionary of Natural Products, version 14.1; Chapman & Hall/CRC: London, 2005.
15. Schreiber, S. L. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science 2000, 287, 1964-1969.
16. Breinbauer, R.; Manger, M.; Scheck, M.; Waldmann, H. Natural product guided compound library development. Curr. Med. Chem. 2002, 23, 2129-2145.
17. Drews, J. Quest of Tomorrow's Medicines; Springer: New York, 2003.
18. Molinspiration Cheminformatics Java toolkit. http://www. molinspiration.com.
19. Ertl, P.; Rohde, B.; Selzer, P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J. Med. Chem. 2000, 43, 3714-3717.
20. CORINA. http://www.mol-net.com.
21. We used a modified version of MOPAC provided by Peter Bladon (Interprobe Chemical Services, Glasgow, U.K.) that is able to calculate additional atomic properties (keyword: PROPER).
22. CLOGP. http://www.biobyte.com.
23. Karelson, M.; Lobanov, V. S.; Katritzky, A. R. Quantum-chemical descriptors in QSAR/QSPR studies. Chem. Rev. 1996, 96, 1027-1044.
24. Selzer, P.; Ertl, P. Identification and classification of GPCR ligands using self-organizing neural networks. Quant. Struct.-Act. Relat. 2005, 24, 270-276.
25. Zupan, J.; Gasteiger, J. Neural Networks in Chemistry and Drug Design; Wiley-VCH: Weinheim, Germany, 1999.
26. Ertl, P.; Selzer, P.; Mühlbacher, J. Web-based cheminformatics tools deployed via corporate intranets. Drug Discovery Today: BIOSILICO 2004, 2, 201-207.
27. Ertl, P. Cheminformatics analysis of organic substituents: identification of the most common substituents, calculation of substituent properties, and automatic identification of drug-like bioisosteric groups. J. Chem. Inf. Comput. Sci. 2003, 43, 374-380.
28. PipelinePilot, version 5.0. http://www.scitegic.com/.